A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
Eisai Inc.
Eisai Inc.
TVAX Biomedical
TVAX Biomedical
Takeda
Capital Medical University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
DNAtrix, Inc.
AbbVie
BBB-Therapeutics B.V.